334 articles by Ricky Zipp

• Boston Scientific continues to win in electrophysiology

  Oct. 22, 2025

• J&J plans to spin out orthopedics business

  Oct. 14, 2025

• Medtech M&A has remained slow this year. But 2 execs are ready to make a deal

  Oct. 8, 2025

• How the FDA’s crackdown on cybersecurity affects medtech firms

  Oct. 7, 2025

• Top medtech conferences in 2026

  Oct. 1, 2025

• Intuitive to lay off 331 employees in California

  Aug. 27, 2025

• 4 medtech topics to watch for the rest of 2025

  Aug. 25, 2025

• Medtronic adds 2 board seats, forms special committees

  Aug. 19, 2025

• Zimmer is latest medtech firm to lower expected tariff hit

  Aug. 7, 2025

• Medtech firms slash expected tariff charges

  July 30, 2025

• Boston Scientific halves expected tariff hit

  July 23, 2025

• ‘We are not rolling over’: J&J electrophysiology unit rebounds amid PFA rivalry

  July 16, 2025

• Will medtech M&A pick back up in the second half?

  July 9, 2025

• Medtronic recall of capsule delivery devices tied to 33 serious injuries

  June 25, 2025

• Beta Bionics CEO, CFO on how to take a company public

  June 2, 2025

• The medtech IPO window is finally open. Or is it?

  May 29, 2025

• Medtronic plans to spin off diabetes business within 18 months

  May 21, 2025

• Cardinal Health cuts employees to offset up to $300M tariff charge

  May 2, 2025

• Trump’s tariff effect has dominated medtech earnings calls

  April 28, 2025

• Boston Scientific is ‘very bullish’ on 2025 despite $200M tariff hit

  April 23, 2025

• J&J’s electrophysiology sales dip amid slow Varipulse start

  April 16, 2025

• J&J expects tariff charge of $400M this year

  April 15, 2025

• AdvaMed continues pressure on White House to exempt devices from tariffs

  April 8, 2025

• HHS to cut 10,000 employees in major restructuring under RFK Jr.

  March 27, 2025

• Solventum cuts 800 positions

  March 26, 2025

• Dr. Oz stresses need for faster Medicare coverage of new devices during confirmation hearing

  March 14, 2025

• Boston Scientific to buy Sonivie for up to $540M

  March 3, 2025

• Medtronic nears FDA submission for Hugo robot

  Feb. 18, 2025

• Inspire Medical reveals DOJ civil investigation

  Feb. 11, 2025

• Boston Scientific closes its year of PFA on a high note

  Feb. 5, 2025

• Top medtech trends in 2025: New products and M&A are bright spots, but Trump brings uncertainty

  Jan. 31, 2025

• Zimmer to buy Paragon 28 for $1.1B

  Jan. 29, 2025

• J&J coordinating with FDA on US pause of Varipulse due to safety risks

  Jan. 22, 2025

• BD expands syringe, needle production capacity in Nebraska and Connecticut

  Jan. 17, 2025

• Philips recall of heart monitor software tied to 109 injuries, 2 deaths

  Jan. 14, 2025

• Medtronic inks distribution deal with Contego with option to buy firm

  Jan. 13, 2025

• 5 medtech trends to watch in 2025

  Jan. 9, 2025

• Stryker to buy Inari Medical for nearly $5B

  Jan. 6, 2025

• Robots, AI and PFA: The top medtech Q&As of 2024

  Dec. 20, 2024

• Trump’s return to office brings uncertainty for medtech industry

  Dec. 18, 2024

• Boston Scientific pacemaker recall tied to 832 injuries, 2 deaths

  Dec. 17, 2024

• CDRH cyber official on compliance with new rules, ongoing security threats

  Dec. 16, 2024

• How Trump’s second term will affect the medtech industry

  Dec. 10, 2024

• Acutus will cut 70% of employees to meet Medtronic obligations

  Dec. 5, 2024

• Advamed CEO stresses need for safety, efficacy after Trump picks Makary to lead FDA

  Nov. 27, 2024

• FDA plan would alert public sooner on high-risk device recalls

  Nov. 22, 2024

• Henry Schein to acquire medical supplier Acentus

  Nov. 21, 2024

• Medtronic’s ablation sales slowed by PFA supply issues

  Nov. 19, 2024

• Boston Scientific closes $3.7B Axonics deal after lengthy review

  Nov. 15, 2024

• 23andMe to lay off more than 200 employees amid business struggles

  Nov. 13, 2024

• Advamed CEO congratulates Trump, stresses need for public policy support

  Nov. 11, 2024

• Tandem, Insulet tout Type 2 expectations as tech attracts new users

  Nov. 8, 2024

• Boston Scientific continues M&A run with Cortex buy

  Nov. 4, 2024

• Abbott CEO sees ‘mass market potential’ for CGMs

  Oct. 16, 2024

• J&J’s recent medtech buys help to prop up devices unit

  Oct. 15, 2024

• Fresenius Medical Care increasing IV, dialysis solutions production to alleviate shortages

  Oct. 11, 2024

• Baxter ups IV fluid allocations amid supply shortages

  Oct. 10, 2024

• Baxter unsure when North Carolina facility hit by Hurricane Helene will be operational

  Oct. 4, 2024

• Top medtech conferences in 2025

  Oct. 1, 2024

• 4 steps to minimize the threat of legacy medical devices

  Sept. 23, 2024

• 23andMe’s independent board directors resign

  Sept. 19, 2024

• Boston Scientific closes Silk Road Medical acquisition

  Sept. 13, 2024

• Dexcom, Abbott OTC glucose sensors add to busy year for diabetes tech

  Sept. 11, 2024

• Judge orders J&J to pay Auris investors more than $1B for merger violations

  Sept. 6, 2024

• Getinge to buy Paragonix organ-preserving tech for up to $477M

  Aug. 23, 2024

• Medtronic: Diabetes strategy hasn’t changed amid Abbott partnership

  Aug. 20, 2024

• FDA OKs first at-home syphilis test

  Aug. 19, 2024

• Boston Scientific resubmits Silk Road merger filing, giving FTC more review time

  Aug. 16, 2024

• Cepheid to cut more than 600 employees in California

  Aug. 8, 2024

• Boston Scientific tips strong growth for Farapulse after successful launch

  July 24, 2024

• Medtech firms have cut more than 14,000 jobs in the past 18 months

  July 17, 2024

• J&J medtech fails to meet growth expectations

  July 17, 2024

• Philips recall of imaging coils tied to 12 injuries

  July 9, 2024

• Dexcom to lay off 535 employees in California

  June 27, 2024

• Baxter recalls ventilation systems for charging malfunctions

  June 27, 2024

• CISA warns of cybersecurity risks in Baxter products

  June 7, 2024

• BD to buy Edwards’ critical care unit for $4.2B

  June 3, 2024

• Surmodics agrees to $627M private equity buyout

  May 31, 2024

• New products take center stage in medtech’s latest earnings season

  May 28, 2024

• Medline, Chinese manufacturer launch recalls for plastic syringes

  May 24, 2024

• Medtronic touts demand for PFA, adding to hype for the new ablation tech

  May 23, 2024

• Medtronic to lay off 44 employees in California

  April 29, 2024

• Livanova says patient data obtained in 2023 cyberattack

  April 26, 2024

• Medtech’s top executive moves in 2024

  April 25, 2024

• Boston Scientific gives first look at Farapulse US rollout

  April 24, 2024

• ‘We think in decades’: J&J’s $30B spending spree may not be over

  April 16, 2024

• J&J to acquire Shockwave Medical for $13.1B

  April 5, 2024

• As cyberattacks on healthcare persist, can the FDA’s new device regs hold up?

  April 3, 2024

• J&J in talks to buy Shockwave Medical: WSJ

  March 27, 2024

• 3M names William Brown CEO

  March 12, 2024

• AI oversight is top challenge facing global device regulators: FDA official

  March 8, 2024

• Medtronic estimates up to 40 job losses in Ireland due to restructuring

  March 5, 2024

• Medtronic will transfer or offer comprehensive support to workers affected by ventilator exit

  Feb. 26, 2024

• Medtronic exits ventilator business, creates new patient monitoring and respiratory unit

  Feb. 20, 2024

• FDA advisory panel overwhelmingly backs Abbott’s Triclip

  Feb. 14, 2024

• Livanova to lay off 137 people at Pittsburgh facility

  Feb. 9, 2024

• Califf backs increased LDT oversight despite industry opposition

  Feb. 1, 2024

• J&J expects strong procedure volumes in 2024

  Jan. 23, 2024

• GAO to review FDA’s oversight of medical device recalls

  Jan. 18, 2024

• 5 medtech trends to watch in 2024

  Jan. 9, 2024

• Roundup: Cyber incidents, vulnerabilities hit the medtech sector in 2023

  Dec. 21, 2023

• SEC charges former Stimwave CEO with $41M fraud scheme

  Dec. 21, 2023

• FDA approves first DNA test for risk of opioid use disorder

  Dec. 20, 2023

• Edwards to spin off its critical care business

  Dec. 8, 2023

• Roundup: Top medtech companies cut jobs in 2023

  Nov. 27, 2023

• Medtronic CEO downplays the impact of obesity drugs on bariatric surgeries, diabetes unit

  Nov. 21, 2023

• Olympus receives Class I recall label for another bronchoscope safety issue

  Nov. 14, 2023

• BD’s 2024 forecast comes in ‘well below’ Wall Street’s expectations

  Nov. 9, 2023

• Siemens Healthineers to lay off 300 workers, move some manufacturing to Ireland

  Nov. 6, 2023

• Stryker in ‘sprint back to 2019’ as procedures grow and supply chain, staffing pressures improve

  Nov. 3, 2023

• FDA extends pandemic-era policy allowing certain device, production changes without prior approval

  Nov. 2, 2023

• Edwards reported double-digit Q3 sales growth, but some analysts are skeptical about 2024

  Oct. 26, 2023

• Olympus recall of abdominal insufflation devices linked to reports of 10 serious injuries, 1 death: FDA

  Oct. 23, 2023

• Bio-Rad, Qiagen are in talks over $10B merger, WSJ reports

  Oct. 10, 2022

• Philips shareholders officially appoint Jakobs as CEO, president

  Sept. 30, 2022

• Friday Q&A: iRhythm CEO Quentin Blackford on how the heart monitor maker plans to reach $1B in sales

  Sept. 30, 2022

• Cyber risks identified in Canon Medical product used to view medical images, security firm says

  Sept. 29, 2022

• Device makers with ethylene oxide facilities at risk of lawsuits after Sterigenics loss: Needham

  Sept. 23, 2022

• Abbott’s latest Amulet-Watchman data show more mixed results for the heart devices

  Sept. 19, 2022

• Baxter’s recall of solution sets used in chemotherapy labeled Class I by FDA amid complaints of leaks

  Sept. 15, 2022

• FBI warns of cyber risks from legacy medical devices

  Sept. 15, 2022

• J&J agrees to settle class action pelvic mesh suits in Australia for more than $200M

  Sept. 13, 2022

• FDA: Reports of squamous cell carcinoma, lymphomas in scar tissue around breast implants

  Sept. 8, 2022

• HHS will allow EUAs for monkeypox tests to increase access in the US

  Sept. 7, 2022

• European Commission blocks Illumina-Grail deal to ‘preserve competition’ in cancer test market

  Sept. 6, 2022

• Friday Q&A: iRhythm CTO Mark Day talks Zio Watch, Verily partnership, Big Tech in healthcare

  Sept. 2, 2022

• Judge rules in favor of Illumina-Grail merger, countering FTC concerns

  Sept. 1, 2022

• Medtronic grows patient monitoring offerings with BioIntelliSense partnership

  Sept. 1, 2022

• Jury orders BD unit to pay $4.8M to patient in latest hernia mesh case

  Aug. 31, 2022

• Philips recalls some BiPAP machines because of contaminated plastic

  Aug. 29, 2022

• FDA takes N95 respirators off medical device shortage list

  Aug. 29, 2022

• Medical device industry poised to withstand an economic slowdown, experts say

  Aug. 22, 2022

• Friday Q&A: ResMed CEO Mick Farrell discusses Philips recall, improving supply chain, prioritizing patients

  Aug. 19, 2022

• Medtronic gets third Class I label in 2022 for latest HVAD recall

  Aug. 19, 2022

• Medical device recalls hit two-year high in Q2, report finds

  Aug. 18, 2022

• Philips’ next CEO, Roy Jakobs, provides ‘continuity’ amid ongoing recall: Barclays

  Aug. 17, 2022

• Philips CEO Frans van Houten to step down in October amid recall woes; Jakobs named successor

  Aug. 16, 2022

• Boston Scientific acquires biomaterials firm Obsidio to bolster embolization business

  Aug. 15, 2022

• ResMed CEO Farrell says supply chain ‘very much in flux’ amid signs of improvement

  Aug. 12, 2022

• Friday Q&A: Francine Kaufman, Senseonics’ CMO, talks growing users, a 365-day CGM, doctor recruitment

  Aug. 12, 2022

• Insulet raises forecast as Omnipod 5 sales climb; Tandem expects tougher market in second half

  Aug. 11, 2022

• Eargo’s Q2 revenue slides amid decline in hearing-aid shipments

  Aug. 9, 2022

• iRhythm raises 2022 revenue forecast after record number of registrations in Q2

  Aug. 5, 2022

• Biden administration declares monkeypox a public health emergency

  Aug. 4, 2022

• BD’s base business growth in Q3 offset by drop in COVID-19 testing

  Aug. 4, 2022

• North American Diagnostics latest to recall COVID-19 tests, gets Class I label from FDA

  Aug. 2, 2022

• Dexcom’s G7 glucose monitor delayed until late 2022; stock price drops 5.6%

  July 29, 2022

• Friday Q&A: Eargo CEO Christian Gormsen talks OTC rule, challenging market leaders, DOJ settlement

  July 29, 2022

• Labcorp lowers forecast after Q2 slowdown, will spin off drug development unit

  July 28, 2022

• Boston Scientific managed COVID-19, economic pressures in Q2, expects procedures to increase

  July 27, 2022

• GE expects supply chain issues to ease in second half after Q2 challenges for health unit

  July 26, 2022

• Philips and U.S. Justice Dept. in consent decree talks on sleep apnea, ventilator recall

  July 25, 2022

• iRhythm, Alphabet unit Verily get FDA clearances for Zio Watch and software system

  July 25, 2022

• Intuitive's da Vinci placements dropped in Q2 due to 'choppy' supply chain, tighter spending by hospitals

  July 22, 2022

• Quest Diagnostics raises 2022 revenue forecast amid continued demand for COVID testing

  July 21, 2022

• Abbott's Q2 sales boosted by COVID-19 testing; outlook for diagnostics demand remains uncertain

  July 20, 2022

• iRhythm says Q2 unit volumes beat forecast, names Chad Patterson as new CCO

  July 19, 2022

• Hologic's stock rating cut by BTIG amid worsening supply chain challenges, drop in COVID testing

  July 18, 2022

• Medtronic warns European healthcare providers of safety problem in defibrillators

  July 15, 2022

• EC publishes IVDR guidance in absence of completed Eudamed database

  July 13, 2022

• Quest launches monkeypox PCR test as U.S. attempts to catch up with rising cases

  July 13, 2022

• Medtronic recalls over 1M dialysis catheters due to malfunction

  July 11, 2022

• Friday Q&A: Roy Jakobs, Philips' head of connected care, talks sleep apnea recall, changing safety protocols

  July 8, 2022

• CMS proposes national rates for cardiac monitoring; iRhythm's stock jumps

  July 8, 2022

• Getinge recalls anesthesia machines due to cracked, broken suction power switches

  July 7, 2022

• As Philips works to replace or repair recalled devices, supply problems are slowing it down

  June 30, 2022

• Sleep apnea devices show 'very low' amount of degraded foam, Philips says

  June 28, 2022

• Patient death prompts another recall of Medtronic's HVAD System

  June 23, 2022

• ResMed to acquire German health software company MediFox for $1B

  June 14, 2022

• Medtronic: No new patient injury, death reports since April letters warning of HVAD defect

  June 9, 2022

• Dexcom CEO Sayer on G7 FDA submission, developing a 15-day sensor, M&A plans

  June 7, 2022

• Medtronic expects diabetes unit's struggles to continue as rivals grow sales, launch products

  June 1, 2022

• How a Dexcom-Insulet combination would shake up the diabetes treatment industry

  May 25, 2022

• Dexcom says it's not in acquisition talks

  May 24, 2022

• FDA gets over 21,000 medical device reports, including 124 deaths, linked to Philips foam breakdown

  May 20, 2022

• Avanos Medical recall gets Class I label from FDA following patient injury, death reports

  May 17, 2022

• Dexcom, Insulet, Tandem start 2022 with revenue growth after weathering omicron surge

  May 13, 2022

• Dexcom Chief Tech Officer Leach discusses G7's European launch and FDA review, expanding Dexcom One

  May 10, 2022

• Earnings week 3: Procedure rebounds, stock price declines, iRhythm's comeback

  May 9, 2022

• Insulet CEO Petrovic to step down on June 1 due to personal reasons; Hollingshead named sucesssor

  May 6, 2022

• CDRH's Shuren expects center to return to normal this year despite ongoing COVID work

  May 2, 2022

• Medtronic, FDA warn providers of HVAD pump malfunctions nearly 1 year after pulled from market

  April 29, 2022

• Medtronic's Covidien has another Class I recall for PB980 ventilators

  April 28, 2022

• Boston Scientific expects more stable 2022 as procedure volumes recover

  April 27, 2022

• Will early trends reported by J&J, Abbott and Intuitive hold in week 2 of earnings?

  April 25, 2022

• Globus Medical CEO resigns in 'surprise' move; stock slips roughly 13%

  April 22, 2022

• J&J saw 'positive signs' of recovery for medtech, but impact from China surge expected in April, May

  April 19, 2022

• Majority of diagnostic companies still implementing IVDR as deadline nears: survey

  April 12, 2022

• Medtronic's recall of over 175,000 MiniMed pumps labeled Class II by FDA

  April 8, 2022

• 'One for the record books': Quidel posts $1B in revenue, beating previous high by nearly $200M

  April 8, 2022

• ‘Where’s the patient?’: Experts question FDA’s final recall guidance

  April 6, 2022

• Nearly 80% of patients with infection following cardiac implant not treated appropriately: study

  April 5, 2022

• Medtronic recalls IN.PACT catheters due to damage during manufacturing

  April 1, 2022

• Congressman asks FDA for information on oversight of Medtronic's troubled HVAD

  March 25, 2022

• FDA labels Philips 2018 field correction for ventilators a Class I recall

  March 22, 2022

• 'Not for the faint of heart': Insulet CEO talks Tandem and Medtronic competition, Omnipod 5 launch

  March 17, 2022

• FDA identified 28 suppliers unaware of Philips sleep device recall

  March 16, 2022

• FDA orders Philips to notify customers about sleep device recall due to 'inadequate' prior efforts

  March 11, 2022

• Intuitive CEO on labor shortages, placements amid the pandemic, new competition

  March 9, 2022

• Medtech industry condemns Russia's invasion of Ukraine

  March 7, 2022

• Diabetes tech leaders expect another year of growth, innovation as competition soars

  Feb. 23, 2022

• What does a more aggressive M&A approach mean for J&J's devices unit?

  Feb. 22, 2022

• Medtronic talks diabetes group's FDA warning letter, new products, supply chain constraints

  Feb. 18, 2022

• Dexcom's G7 gains CE mark after 2021 delay

  Feb. 11, 2022

• J&J's DePuy Synthes buys ortho company CrossRoads Extremity Systems

  Feb. 10, 2022

• Zimmer gives investors first look at its dental and spine spinoff

  Feb. 8, 2022

• 3 key FDA topics for medtechs in 2022

  Feb. 1, 2022

• 4 key trends for procedure-reliant medtechs in 2022

  Jan. 27, 2022

• J&J's device recovery slowed by omicron surge, with impact expected over next several months

  Jan. 25, 2022

• Medtronic's HawkOne recall labeled Class I, adding to medtech's product safety problems

  Jan. 21, 2022

• Tandem CEO on Omnipod 5 competition, pharmacy distribution, Type 2 growth

  Jan. 20, 2022

• Dexcom CEO on G7's global launch, COVID-19 slowing new patient adds, international growth

  Jan. 18, 2022

• Philips ups recall provisions by $250M, impacted devices to more than 5M

  Jan. 12, 2022

• iRhythm stock jumps nearly 28% after Novitas doubles Medicare rates for cardiac monitoring

  Jan. 11, 2022

• Medtronic CEO: Company on track to hit guidance, omicron impact 'uncertain'

  Jan. 10, 2022

• Wall Street backs Stryker-Vocera strategic fit but split on valuation

  Jan. 6, 2022

• FDA warning letter cites product safety issues in Medtronic diabetes group

  Jan. 5, 2022

• Philips: Compounds in recalled devices 'not typically' associated with long-term health risks

  Dec. 23, 2021

• J&J device chief on company split, omicron surge, robotic surgery

  Dec. 20, 2021

• Medtronic's stock price falls nearly 9% following FDA warning letter

  Dec. 15, 2021

• Medtronic's Covidien initiates ventilator recall due to manufacturing error

  Dec. 14, 2021

• Edwards sees double-digit 2022 sales growth boosted by another TAVR jump

  Dec. 9, 2021

• Tandem Diabetes Care targets 1M customers by 2027

  Dec. 7, 2021

• Insulet's Omnipod 5 insulin pump cleared by FDA after months of delays, sending shares up 9%

  Dec. 6, 2021

• Device recalls jumped 36% in Q3, first quarterly increase since 2020: report

  Dec. 3, 2021

• New iRhythm CEO talks Medicare pricing, larger medtech competitors, international markets

  Nov. 19, 2021

• What does J&J's split mean for the medical device business?

  Nov. 16, 2021

• J&J splitting medical device, pharma units from consumer health brands

  Nov. 12, 2021

• After another successful quarter, diabetes tech players look ahead to key product launches

  Nov. 11, 2021

• iRhythm's COVID-19 pressures add to Medicare pricing saga

  Nov. 5, 2021

• CMS reinstates Medicare's inpatient-only list in final rule, reversing Trump-era nix

  Nov. 3, 2021

• What does J&J's Ottava delay mean for Intuitive and Medtronic? It's complicated.

  Oct. 28, 2021

• Boston Scientific CEO projects better Q4 and 2022 as delta surge wanes

  Oct. 27, 2021

• Medtronic surgical robotics head talks Hugo, taking on Intuitive, COVID-19 challenges

  Oct. 20, 2021

• J&J delays Ottava robot rollout as global medtech business boosts Q3 sales

  Oct. 19, 2021

• Anatomy of a medical device recall: How defective products can slip through an outdated system

  Oct. 18, 2021

• Biden circling former FDA chief Califf to again lead agency: report

  Oct. 15, 2021

• Medtronic's surgical robot Hugo gains CE mark, setting up Intuitive faceoff

  Oct. 11, 2021

• Boston Scientific inks $1.75B deal for Baylis, biggest in string of M&A

  Oct. 6, 2021

• Boston Scientific CEO: 'Unprecedented' shutdown from delta to hit Q3

  Sept. 23, 2021

• Boston Scientific to spend $269M for remaining stake of Devoro in latest deal

  Sept. 21, 2021

• Medtechs are boosting DTC investment, but industry still years behind pharma

  Sept. 14, 2021

• iRhythm announces new CEO, the second since December, amid tumultuous 2021

  Sept. 13, 2021

• ECRI CEO: FDA, industry must revisit COVID-19 medical device EUAs as shortages ebb

  Sept. 3, 2021

• Medtechs made it out of Q2 with minimal impact from delta. That could change in Q3.

  Aug. 26, 2021

• Medtronic starts FY22 with electives boost, but delta hits in summer months

  Aug. 24, 2021

• Zimmer's Rosa total hip system gets FDA nod, fueling robotics rivalry

  Aug. 18, 2021

• Abbott's Amulet FDA approval sets stage for US market fight with Boston Scientific

  Aug. 16, 2021

• Diabetes tech companies set sights on Type 2 patients as user numbers climb

  Aug. 9, 2021

• iRhythm doesn't expect 2022 CMS pricing. 'It may take some time.'

  Aug. 6, 2021

• Hillrom reverses course, will finalize $375M BardyDx acquisition

  Aug. 2, 2021

• Patient deaths called 'injury,' 'other' in FDA medical device database: study

  July 30, 2021

• Boston Scientific tops pre-pandemic results in Q2, expects similar trends in H2

  July 27, 2021

• FDA labels Philips sleep apnea, ventilator recall Class I, ResMed eyes advantage

  July 23, 2021

• CDRH still digging out of backlog caused by COVID-19: Shuren

  July 22, 2021

• J&J medical device sales return to pre-pandemic levels in Q2 as COVID-19 impact wanes

  July 21, 2021

• Medtech M&A expected to be robust in second half after 2021 began with a flurry

  July 18, 2021

• NuVasive's scoliosis system gets reinstated CE mark, new instructions for use

  July 16, 2021

• Dexcom wins FDA nod for real-time APIs, allowing third-party developers access to CGM data

  July 16, 2021

• CMS again passes on national pricing for long-term cardiac monitoring, dramatically reduced rates remain

  July 14, 2021

• Medtech pay to doctors plunged in 2020 as COVID-19 pummeled electives, in-person services fell

  July 12, 2021

• Hillrom ordered to complete BardyDx transaction by Delaware court

  July 12, 2021

• Dexcom CEO on the Type 2 population, the Super Bowl ad and pandemic momentum

  July 6, 2021

• Medtronic smart insulin pen improved time in target blood glucose levels: study

  June 29, 2021

• Boston Scientific spends $295M to snap up rest of cardiac ablation maker Farapulse

  June 24, 2021

• AdvaMed urges Biden to prioritize medical supplies as industries suffer shipping constraints

  June 23, 2021

• Medicare CGM eligibility widened in potential boon for Abbott, Dexcom

  June 18, 2021

• ResMed's stock climbs following Philips' sleep apnea, ventilator device recall

  June 14, 2021

• Medtronic's HeartWare HVAD ending brings questions about $1B acquisition

  June 8, 2021

• Medtronic pulls HeartWare HVAD pump from market amid recalls, patient deaths

  June 3, 2021

• Amid pricing tumult, iRhythm CEO resigns after 4 months in office

  June 2, 2021

• Medtronic HeartWare system hit with slew of Class I recalls, device reports since 2012 PMA

  May 21, 2021

• Edwards tricuspid valve replacement cut leakage for 98% of participants in early trial results

  May 17, 2021

• Diabetes tech companies continue 2020's success with Q1 growth. Investors seem unimpressed.

  May 12, 2021

• Medtronic hit with another Class I recall regarding HeartWare HVAD system

  May 12, 2021

• iRhythm again meets with Medicare rate setter after cardiac monitoring pay cut by nearly $200

  May 7, 2021

• Zimmer sees Q1 sales growth after CEO warned of down quarter

  May 4, 2021

• Radiology Partners, Aidoc talk AI adoption, handling bias, FDA actions

  May 3, 2021

• Boston Scientific sees Q1 electives rebound, hints at further 2021 M&A

  April 28, 2021

• Edwards withstands winter lows, grows Q1 sales on electives recovery

  April 21, 2021

• J&J returns to growth in Q1 as elective care rebounds in US, Asia-Pacific

  April 20, 2021

• BD files new 510(k) submission for troubled Alaris infusion pump

  April 19, 2021

• EU MDR delay has not made new rules easier to stomach: exec poll

  April 15, 2021

• iRhythm's future hazy after Medicare pricing saga erases 12-month high

  April 13, 2021

• iRhythm shares tank after Medicare rates surprise

  April 12, 2021

• Medtronic's robotic spine market lead threatened as smaller rivals look to edge in

  April 9, 2021

• Medtechs top pharma in cash to doctors for consulting, travel: Health Affairs study

  April 6, 2021

• Quest sells minority share of Q2 Solutions for $760M

  April 1, 2021

• Stryker, Zimmer make data and analytics a top priority as robotic procedures ramp up

  March 25, 2021

• Insulet's Omnipod 5 trial shows benefits across patient groups with Type 1 diabetes

  March 22, 2021

• ASCs gave medtechs alternate care sites amid pandemic hospital elective shutdown

  March 19, 2021

• CGM patients seen rising 38% in 2021 fueled by Type 2 diabetes: poll

  March 18, 2021

• Robotics demand held firm as pandemic pummeled electives

  March 18, 2021

• Abbott halts trial enrollment for HeartMate PHP catheter blood pump

  March 17, 2021

• All eyes on elective care after a rollercoaster year for medtech

  March 16, 2021

• Cardiac wearables, iRhythm, under a cloud as reimbursement questions linger

  March 15, 2021

• Insulin pump adoption seen climbing 21% in 2021 on wearables boom: survey

  March 5, 2021

• Boston Scientific puts up $1B in cash to buy Lumenis surgical line from private equity

  March 3, 2021

• iRhythm still faces reimbursement uncertainty after meetings with Medicare rate negotiator

  Feb. 26, 2021

• Diabetes wearables look resilient through 2021, bucking broad medtech trends

  Feb. 25, 2021

• BD drug-coated balloon falls short at FDA panel, signaling likely rejection

  Feb. 18, 2021

• Dexcom touts boost from Super Bowl ad, sidesteps access complaints

  Feb. 12, 2021

• What medtech earnings tell us so far: COVID-19 testing, electives hit, and M&A

  Feb. 11, 2021

• Dexcom's Super Bowl ad puts focus on cost, access issues in diabetes tech

  Feb. 9, 2021

• Zimmer takes electives hit in Q4, to spin off spine, dental units

  Feb. 5, 2021

• BD posts better-than-expected COVID-19 test sales, but flagship Veritor revenues to slow

  Feb. 4, 2021

• Boston Scientific sees COVID-19 electives pressure in Q1, recovery in second half

  Feb. 3, 2021

• Low Medicare EKG device draft slams iRhythm, stock price sinks by over 30%

  Jan. 29, 2021

• CGM, insulin pump players look to 2021 as watershed year for diabetes wearables market

  Jan. 29, 2021

• New iRhythm CEO on national pricing setback, Medtronic market expansion lessons

  Jan. 28, 2021

• Stryker falls short of Q4 sales amid electives pullback, robotics a bright spot

  Jan. 27, 2021

• J&J misses Wall Street on hips, knees and spine amid global elective care slowdown

  Jan. 26, 2021

• Abbott, Edwards focus on mitral valve as market projected to rival TAVR

  Jan. 25, 2021

• Boston Scientific bets on cardiac wearables with $925M Preventice buy

  Jan. 21, 2021

• CMS expands transcatheter mitral coverage, boosting Abbott's MitraClip device

  Jan. 20, 2021

• Philips to acquire Capsule Technologies in $635M deal, growing patient data capabilities

  Jan. 19, 2021

• Remote monitoring, wearable companies look to capitalize on virtual care boom: JPM21

  Jan. 14, 2021

• Steris inks $4.6B buy of Cantel Medical amid flurry of M&A

  Jan. 13, 2021

• 3 takeaways from JP Morgan: Electives, M&A and looking past COVID-19

  Jan. 12, 2021

• Medtech M&A to take off after pandemic slowed deals in 2020: EY

  Jan. 10, 2021

• Quidel prelim Q4 revenue miss 'a big surprise' to Wall Street

  Jan. 8, 2021

• Wall Street paints rosy 2021 for medtech as electives snap back

  Jan. 7, 2021

• Hologic's $230M Biotheranostics buy its 2nd M&A deal of 2021

  Jan. 6, 2021

• Medtech's COVID-19 recovery will have to wait for second half of 2021: analysts

  Dec. 21, 2020

• Philips buys cardiac monitoring company BioTelemetry in $2.8B deal

  Dec. 18, 2020

• At FDA's request, Penumbra recalls catheter device after 14 patient deaths

  Dec. 17, 2020

• Stryker, Zimmer shift strategies to capitalize on growing ASC market

  Dec. 16, 2020

• Medtronic's Coyle to replace iRhythm CEO King in switch-up

  Dec. 15, 2020

• Edwards plots TAVR comeback even as COVID-19 surge hits harder

  Dec. 10, 2020

• Dexcom lays out strategy to double revenue by 2025, eyes hospitals, new markets

  Dec. 9, 2020

• Boston Scientific's Lotus ditch creates 'duopoly' in growing TAVR market

  Dec. 8, 2020

• CDRH headed for 'reset' in 2021 after COVID-19 derailed priorities, Shuren says

  Dec. 3, 2020

• CMS adds hip replacements, other surgeries to ASC list in final rule

  Dec. 3, 2020

• Medical device makers get more flexibility with value-based care in Stark, anti-kickback final rules

  Nov. 24, 2020